Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

DS Wald, M Law, JK Morris - Bmj, 2002 - bmj.com
Objective: To assess whether the association of serum homocysteine concentration with
ischaemic heart disease, deep vein thrombosis and pulmonary embolism, and stroke is causal …

Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials

DS Wald, M Law, JK Morris, JP Bestwick… - The American journal of …, 2009 - Elsevier
OBJECTIVE: To quantify the incremental effect of combining blood pressure-lowering drugs
from any 2 classes of thiazides, beta-blockers, angiotensin-converting enzyme inhibitors, …

[HTML][HTML] Randomized trial of preventive angioplasty in myocardial infarction

DS Wald, JK Morris, NJ Wald, AJ Chase… - … England Journal of …, 2013 - Mass Medical Soc
Background In acute ST-segment elevation myocardial infarction (STEMI), the use of
percutaneous coronary intervention (PCI) to treat the artery responsible for the infarct (infarct, or …

Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients

SH Naderi, JP Bestwick, DS Wald - The American journal of medicine, 2012 - Elsevier
OBJECTIVE: Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering
drugs, substantially reduces the risk of coronary heart disease, but the full …

[HTML][HTML] Child–parent familial hypercholesterolemia screening in primary care

DS Wald, JP Bestwick, JK Morris, K Whyte… - … England Journal of …, 2016 - Mass Medical Soc
Background Child–parent screening for familial hypercholesterolemia has been proposed
to identify persons at high risk for inherited premature cardiovascular disease. We assessed …

Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence

DS Wald, NJ Wald, JK Morris, M Law - Bmj, 2006 - bmj.com
Increasing intake of folic acid would be a relatively cheap and simple way of reducing heart
disease, if it works. Can we draw a definitive conclusion from the current evidence?

Randomized trial of folic acid supplementation and serum homocysteine levels

DS Wald, L Bishop, NJ Wald, M Law… - Archives of internal …, 2001 - jamanetwork.com
Background Lowering ser um homocysteine levels with folic acid is expected to reduce
mortality from ischemic heart disease. Homocysteine reduction is known to be maximal at a folic …

Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action

…, M Kayikçioğlu, S Koob, M Koseki, S Lane… - JAMA …, 2020 - jamanetwork.com
Importance Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated
genetic disorder that leads to premature morbidity and mortality due to atherosclerotic …

Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis

DS Wald, JP Bestwick, NJ Wald - Bmj, 2007 - bmj.com
Objective To develop a population screening strategy for familial hypercholesterolaemia.
Design Meta-analysis of published data on total and low density lipoprotein (LDL) cholesterol …

[HTML][HTML] Randomized polypill crossover trial in people aged 50 and over

DS Wald, JK Morris, NJ Wald - 2012 - journals.plos.org
Background A Polypill is proposed for the primary prevention of cardiovascular disease in
people judged to be at risk on account of their age alone. Its efficacy in reducing cholesterol …